InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by CARDOZA GEORGE, Chief Financial Officer. Insider active across 2 companies, notably SOPHiA GENETICS SA. Cumulatively, 9 disclosures have been recorded. Total volume traded: €11.2m. The latest transaction was filed on 2 April 2026 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
0112,936 shares0
Ordinary Shares
SEC:0001840706-26-000108·
0112,936 shares0
Ordinary Shares
SEC:0001840706-26-000108:0·
0503 shares0
Common Stock
SEC:0001077183-22-000041:0·
061,143 shares0
Common Stock
SEC:0001077183-21-000277·
061,143 shares0
Common Stock
SEC:0001077183-21-000277:0·
07,584 shares0
Common Stock
SEC:0001077183-21-000187·
07,584 shares0
Common Stock
SEC:0001077183-21-000187:0·
€6m169,230 shares@ €33.07980.52% mcap100.0% of flow
Common Stock
SEC:0001077183-21-000155·
€6m169,230 shares@ €33.07980.52% mcap50.0% of flow
Common Stock
SEC:0001077183-21-000155:0·
9 of 9 declarations
About CARDOZA GEORGE
George Cardoza is the Chief Financial Officer and President of Pharma Services at SOPHiA GENETICS SA and NEOGENOMICS INC. In this role, he oversees the financial and strategic operations of both companies. Cardoza plays a key role in guiding financial strategy and managing resources to ensure growth and innovation. His expertise is essential for the success of both organizations.
